CRP and metabolic syndrome: As shown in Figures 1 and 2, age- and sex-adjusted BMI, waist circumference, HbA1c, fasting plasma glucose, HOMA2-IR, triglyceride, HS-CRP and prevalence of metabolic syndrome decreased dose-dependently as T-LTPA increased (p for trend all <0.001 for BMI, waist circumference, HbA1c, fasting plasma glucose, HOMA2-IR, triglyceride, HS-CRP, and prevalence of metabolic syndrome).